Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Other Non-Current Assets (2020 - 2025)

Silo Pharma's Other Non-Current Assets history spans 6 years, with the latest figure at $56226.0 for Q2 2025.

  • For Q2 2025, Other Non-Current Assets fell 9.41% year-over-year to $56226.0; the TTM value through Jun 2025 reached $56226.0, down 9.41%, while the annual FY2024 figure was $59145.0, 8.98% down from the prior year.
  • Other Non-Current Assets for Q2 2025 was $56226.0 at Silo Pharma, up from $48125.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $70821.0 in Q4 2022 and bottomed at $19375.0 in Q1 2021.
  • The 5-year median for Other Non-Current Assets is $61334.0 (2024), against an average of $53139.7.
  • The largest annual shift saw Other Non-Current Assets surged 165.66% in 2022 before it decreased 24.24% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $26659.0 in 2021, then soared by 165.66% to $70821.0 in 2022, then fell by 8.24% to $64983.0 in 2023, then decreased by 8.98% to $59145.0 in 2024, then fell by 4.94% to $56226.0 in 2025.
  • Per Business Quant, the three most recent readings for SILO's Other Non-Current Assets are $56226.0 (Q2 2025), $48125.0 (Q1 2025), and $59145.0 (Q4 2024).